Skip to Content

MYLAN 6725 MYLAN 6725 (Zonisamide 25 mg)

Pill with imprint MYLAN 6725 MYLAN 6725 is Purple, Capsule-shape and has been identified as Zonisamide 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Zonisamide is used in the treatment of seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 6725 MYLAN 6725

Zonisamide 25 mg MYLAN 6725 MYLAN 6725
Zonisamide 25 mg MYLAN 6725 MYLAN 6725
Zonisamide 25 mg MYLAN 6725 MYLAN 6725
Zonisamide 25 mg MYLAN 6725 MYLAN 6725

Zonisamide

Imprint
MYLAN 6725 MYLAN 6725
Strength
25 mg
Color
Purple
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-6725
Inactive Ingredients
lactose anhydrous, ferrosoferric oxide, silicon dioxide, D&C Yellow No. 10, D&C Red No. 28, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, magnesium stearate, microcrystalline cellulose, propylene glycol, shellac, sodium lauryl sulfate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.